OPGN
Price:
$1.75
Market Cap:
$14.62M
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artifici...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2015-05-05
Stock Exchange
NASDAQ
Ticker
OPGN
According to OpGen, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.92M. This represents a change of 59.18% compared to the average of 17.54M of the last 4 quarters.
The mean historical Enterprise Value of OpGen, Inc. over the last ten years is 121.85M. The current 27.92M Enterprise Value has changed 2.19% with respect to the historical average. Over the past ten years (40 quarters), OPGN's Enterprise Value was at its highest in in the March 2015 quarter at 522.59M. The Enterprise Value was at its lowest in in the December 2019 quarter at 5.14M.
Average
121.85M
Median
57.37M
Minimum
14.28M
Maximum
521.93M
Discovering the peaks and valleys of OpGen, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 122.83%
Maximum Annual Enterprise Value = 521.93M
Minimum Annual Increase = -75.18%
Minimum Annual Enterprise Value = 14.28M
Year | Enterprise Value | Change |
---|---|---|
2023 | 15.20M | 6.42% |
2022 | 14.28M | -44.58% |
2021 | 25.77M | -38.23% |
2020 | 41.72M | 122.83% |
2019 | 18.72M | -75.18% |
2018 | 75.44M | 3.32% |
2017 | 73.01M | -63.55% |
2016 | 200.33M | -13.68% |
2015 | 232.08M | -55.53% |
2014 | 521.93M | 0.68% |
The current Enterprise Value of OpGen, Inc. (OPGN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
18.42M
5-year avg
23.14M
10-year avg
121.85M
OpGen, Inc.’s Enterprise Value is greater than Bone Biologics Corporation (372.73K), greater than NanoVibronix, Inc. (-452705.00), greater than Bluejay Diagnostics, Inc. (-6409922.00), greater than Vivos Therapeutics, Inc. (7.68M), greater than Tivic Health Systems, Inc. (-1899758.00), greater than Heart Test Laboratories, Inc. (-834267.00), greater than NeuroMetrix, Inc. (6.29M), greater than ReShape Lifesciences Inc. (2.13M), greater than Inspira Technologies Oxy B.H.N. Ltd. (19.23M), less than Sight Sciences, Inc. (151.28M), greater than STRATA Skin Sciences, Inc. (22.33M), less than NeuroPace, Inc. (246.80M), less than Vapotherm, Inc. (133.30M), greater than Talis Biomedical Corporation (-37931750.00), greater than Nuwellis, Inc. (4.84M), greater than Nemaura Medical Inc. (19.51M), greater than Movano Inc. (9.28M), greater than INVO Bioscience, Inc. (7.69M), less than enVVeno Medical Corporation (42.68M),
Company | Enterprise Value | Market cap |
---|---|---|
372.73K | $2.70M | |
-452705.00 | $1.58M | |
-6409922.00 | $1.21M | |
7.68M | $12.82M | |
-1899758.00 | $1.79M | |
-834267.00 | $2.49M | |
6.29M | $7.72M | |
2.13M | $3.07M | |
19.23M | $23.68M | |
151.28M | $234.43M | |
22.33M | $12.64M | |
246.80M | $185.98M | |
133.30M | $13.55M | |
-37931750.00 | $3.14M | |
4.84M | $5.21M | |
19.51M | $8.07K | |
9.28M | $26.00M | |
7.69M | $3.25M | |
42.68M | $59.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OpGen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OpGen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is OpGen, Inc.'s Enterprise Value?
What is the highest Enterprise Value for OpGen, Inc. (OPGN)?
What is the 3-year average Enterprise Value for OpGen, Inc. (OPGN)?
What is the 5-year average Enterprise Value for OpGen, Inc. (OPGN)?
How does the current Enterprise Value for OpGen, Inc. (OPGN) compare to its historical average?